Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractThe effect of synthetic female sex pheromone on the transmission of the fungus Metarhizium brunneum by male Agriotes obscurus click beetles    Next AbstractOccupational exposure to volatile organic compounds and mitigation by push-pull local exhaust ventilation in printing plants »

Burns


Title:Accelerant-related burns and drug abuse: Challenging combination
Author(s):Leung LTF; Papp A;
Address:"Division of Plastic & Reconstructive Surgery, University of British Columbia, Vancouver, B.C., Canada. Electronic address: leslietfleung@alumni.ubc.ca. Division of Plastic & Reconstructive Surgery, University of British Columbia, Vancouver, B.C., Canada"
Journal Title:Burns
Year:2018
Volume:44
Issue:3
Page Number:646 - 650
DOI: 10.1016/j.burns.2017.10.010
ISSN/ISBN:1879-1409 (Electronic) 0305-4179 (Linking)
Abstract:"BACKGROUND: Accelerants are flammable substances that may cause explosion when added to existing fires. The relationships between drug abuse and accelerant-related burns are not well elucidated in the literature. Of these burns, a portion is related to drug manufacturing, which have been shown to be associated with increased burn complications. OBJECTIVES: 1) To evaluate the demographics and clinical outcomes of accelerant-related burns in a Provincial Burn Centre. 2) To compare the clinical outcomes with a control group of non-accelerant related burns. 3) To analyze a subgroup of patients with history of drug abuse and drug manufacturing. METHODS: Retrospective case control study. Patient data associated with accelerant-related burns from 2009 to 2014 were obtained from the British Columbia Burn Registry. These patients were compared with a control group of non-accelerant related burns. Clinical outcomes that were evaluated include inhalational injury, ICU length of stay, ventilator support, surgeries needed, and burn complications. Chi-square test was used to evaluate categorical data and Student's t-test was used to evaluate mean quantitative data with the p value set at 0.05. A logistic regression model was used to evaluate factors affecting burn complications. RESULTS: Accelerant-related burns represented 28.2% of all burn admissions (N=532) from 2009 to 2014. The accelerant group had higher percentage of patients with history of drug abuse and was associated with higher TBSA burns, ventilator support, ICU stay and pneumonia rates compared to the non-accelerant group. Within the accelerant group, there was no difference in clinical outcomes amongst people with or without history of drug abuse. Four cases were associated with methamphetamine manufacturing, all of which underwent ICU stay and ventilator support. CONCLUSIONS: Accelerant-related burns cause significant burden to the burn center. A significant proportion of these patients have history of drug abuse"
Keywords:Adult Amphetamine-Related Disorders/epidemiology Body Surface Area British Columbia Burns/*epidemiology/surgery Butanes Case-Control Studies Ethanol *Explosive Agents Female Gasoline Graft Survival Humans Intensive Care Units Length of Stay/statistics & n;
Notes:"MedlineLeung, Leslie T F Papp, Anthony eng Netherlands 2017/11/05 Burns. 2018 May; 44(3):646-650. doi: 10.1016/j.burns.2017.10.010"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 23-09-2024